Literature DB >> 34623619

Pregnancy-onset thrombotic thrombocytopenic purpura with nephrotic syndrome: a case report.

Ryunosuke Noda1, Yuki Kakinuma2, Kensuke Suzuki2, Sanae Ide2, Yuan Bae3, Akito Miyauchi2, Yoshitaka Ishibashi4.   

Abstract

Pregnancy-onset thrombotic thrombocytopenic purpura (TTP) was reported by many obstetricians and hematologists, but less by nephrologists, and the detailed clinical course of its renal complication is not known. Here, we report a case of a 33-year-old pregnant woman who suffered from pregnancy-onset TTP with nephrotic syndrome which was controlled by the termination of pregnancy. On admission, she had periorbital and lower leg edema at 32 weeks of gestation. Her serum albumin level was 2.8 g/dL and the urine protein/creatinine ratio was 4.1 g/g Cr. Besides those, she had thrombocytopenia, hemolytic anemia, and severe deficiency of A Disintegrin-like and Metalloproteinase with Thrombospondin type 1 motifs 13 (ADAMTS-13) activity. Thus, she was diagnosed with nephrotic syndrome due to pregnancy-onset TTP. A cesarean section was performed without complications for the patient and her baby. Then, all her symptoms improved shortly. She was suspected of congenital TTP because of no ADAMTS-13 inhibitor results and the persistent deficiency of ADAMTS-13 activity even after her condition improved. Pregnancy-onset TTP can cause nephrotic syndrome. Termination of pregnancy should be considered in cases with pregnancy-onset TTP to protect kidney function.
© 2021. Japanese Society of Nephrology.

Entities:  

Keywords:  Nephrotic syndrome; Pregnancy; Thrombotic microangiopathy (TMA); Thrombotic thrombocytopenic purpura (TTP)

Mesh:

Substances:

Year:  2021        PMID: 34623619      PMCID: PMC9061906          DOI: 10.1007/s13730-021-00654-2

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  20 in total

1.  TTP in the setting of pregnancy: The story still has to be written.

Authors:  Paul Coppo; Agnès Veyradier
Journal:  J Thromb Haemost       Date:  2020-10       Impact factor: 5.824

2.  Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.

Authors:  Fadi Fakhouri; Marie Scully; François Provôt; Miquel Blasco; Paul Coppo; Marina Noris; Kathy Paizis; David Kavanagh; Frédéric Pène; Sol Quezada; Alexandre Hertig; Sébastien Kissling; Patrick O'Brien; Yahsou Delmas; Lorenzo Alberio; Norbert Winer; Agnès Veyradier; Spero Cataland; Véronique Frémeaux-Bacchi; Chantal Loirat; Giuseppe Remuzzi; Vassilis Tsatsaris
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

Review 3.  Thrombotic microangiopathies of pregnancy: Differential diagnosis.

Authors:  M Gupta; B B Feinberg; R M Burwick
Journal:  Pregnancy Hypertens       Date:  2018-02-16       Impact factor: 2.899

4.  Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

Authors:  P M Mannucci; M T Canciani; I Forza; F Lussana; A Lattuada; E Rossi
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

Review 5.  Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.

Authors:  Y Fujimura; M Matsumoto; A Isonishi; H Yagi; K Kokame; K Soejima; M Murata; T Miyata
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

6.  Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients.

Authors:  Yoshihiro Fujimura; Masanori Matsumoto; Koichi Kokame; Ayami Isonishi; Kenji Soejima; Nobu Akiyama; Junji Tomiyama; Kazuhiko Natori; Yasunobu Kuranishi; Yutaka Imamura; Nobumasa Inoue; Satoshi Higasa; Masako Seike; Teruhiko Kozuka; Masamichi Hara; Hideo Wada; Mitsuru Murata; Yasuo Ikeda; Toshiyuki Miyata; James N George
Journal:  Br J Haematol       Date:  2008-11-26       Impact factor: 6.998

7.  How I treat thrombotic thrombocytopenic purpura in pregnancy.

Authors:  Barbara Ferrari; Flora Peyvandi
Journal:  Blood       Date:  2020-11-05       Impact factor: 22.113

8.  Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes.

Authors:  Marie Scully; Mari Thomas; Mary Underwood; Henry Watson; Katherine Langley; Raymond S Camilleri; Amanda Clark; Desmond Creagh; Rachel Rayment; Vickie Mcdonald; Ashok Roy; Gillian Evans; Siobhan McGuckin; Fionnuala Ni Ainle; Rhona Maclean; William Lester; Michael Nash; Rosemary Scott; Patrick O Brien
Journal:  Blood       Date:  2014-05-23       Impact factor: 22.113

9.  The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.

Authors:  Hendrika A van Dorland; Magnus Mansouri Taleghani; Kazuya Sakai; Kenneth D Friedman; James N George; Ingrid Hrachovinova; Paul N Knöbl; Anne Sophie von Krogh; Reinhard Schneppenheim; Isabella Aebi-Huber; Lukas Bütikofer; Carlo R Largiadèr; Zuzana Cermakova; Koichi Kokame; Toshiyuki Miyata; Hideo Yagi; Deirdra R Terrell; Sara K Vesely; Masanori Matsumoto; Bernhard Lämmle; Yoshihiro Fujimura; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

10.  Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura.

Authors:  Minola Manea; AnnCharlotte Kristoffersson; Reinhard Schneppenheim; Moin A Saleem; Peter W Mathieson; Matthias Mörgelin; Peter Björk; Lars Holmberg; Diana Karpman
Journal:  Br J Haematol       Date:  2007-07-12       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.